Electra Therapeutics (ETRA) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 11 32 sessions, September 18, 2026 to November 2, 2026
- Largest daily move
- -9.8% close of November 2, 2026
- 1-month change
- -29.5% closing prices, October 2, 2026 to November 2, 2026
Company Description
Electra Therapeutics (NASDAQ: ETRA) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $458.8M.
ETRA has declined 29.5% over the past month. The last closing price was $7.31.
This page collects what Stock Titan holds for ETRA, including price data, latest news, SEC filings, insider trading activity, and short interest trends.
Stock Performance
Electra Therapeutics (ETRA) closed at $7.31 on November 2, 2026. Over the past month, the price has lost 29.5%.
ETRA Metrics & Rankings
Price returns through November 2, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Electra Therapeutics has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include IPO, offering. View all ETRA news →
SEC Filings
Electra Therapeutics has filed 10 recent SEC filings, including 5 Form 4, 3 Form SCHEDULE 13G, 1 Form 3, 1 Form SCHEDULE 13D. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ETRA SEC filings →
Insider Radar
Insider buying activity at Electra Therapeutics over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Short Interest History
Short interest in Electra Therapeutics (ETRA) currently stands at 409.4 thousand shares, down 41.7% from the previous reporting period, representing 1.8% of the float. Since September 2026, short interest has decreased by 41.7%.
Days to Cover History
Days to cover for Electra Therapeutics (ETRA) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
ETRA Company Profile & Sector Positioning
Electra Therapeutics (ETRA) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing ETRA often look at related companies in the same sector, including Valneva SE (VALN), Arvinas, Inc (ARVN), CytomX Therapeutics, Inc. (CTMX), Oculis Holding AG (OCS), and Crescent Biopharma, Inc. (CBIO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ETRA's relative position within its industry.